Comparative aspects of cancer immunotherapy: immunologic methods used for treatment of spontaneous cancer in animals.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000818:Animals; D001500:BCG Vaccine / Q000627:therapeutic use; D001427:Bacterial Toxins / Q000627:therapeutic use; D002371:Cat Diseases / Q000276:immunology / Q000628:therapy; D002415:Cats; D002417:Cattle; D004137:Dinitrochlorobenzene / Q000627:therapeutic use; D004283:Dog Diseases / Q000188:drug therapy / Q000276:immunology / Q000628:therapy; D004285:Dogs; D005620:Freund's Adjuvant / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy / Q000662:veterinary*; D007978:Levamisole / Q000627:therapeutic use; D008070:Lipopolysaccharides / Q000627:therapeutic use; D008223:Lymphoma / Q000188:drug therapy; D009369:Neoplasms / Q000276:immunology / Q000628:therapy / Q000662:veterinary*; D011425:Propionibacterium acnes / Q000276:immunology; D012705:Serratia / Q000276:immunology; D013291:Streptococcus / Q000276:immunology
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine; D001427:Bacterial Toxins; D004137:Dinitrochlorobenzene; D008070:Lipopolysaccharides; C011499:methanol extraction residue (MER) tubercle bacillus fraction; D007978:Levamisole; D005620:Freund's Adjuvant